AIQ Solutions: Clinical Trials

3 trials sponsored by AIQ Solutions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1
Phase 21Active not recruiting 1

Follow AIQ Solutions: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comprehensive Assessment of Cancer Theranostic Response
TRAQinform Theranostics - Prostate Cancer
Not applicableActive not recruitingAIQ Solutions252024-12-022026-10-06
TRAQinform Assessment of Immunotherapy Response
Non-Interventional - Melanoma
CompletedAIQ Solutions262023-06-232025-08-28
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
pTVG-HP, Nivolumab, GM-CSF - Prostate Cancer
Phase 2Active not recruitingUniversity of Wisconsin, Madison192018-09-102026-06-01

Conditions studied

Prostatic Neoplasms (2)  ·  Melanoma (1)

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Nivolumab (1)  ·  sargramostim (1)

Countries

United States (3)

Top investigators

Hamid Emamekhoo (1)

Results publications

PMID 38101860

NIH funding

R44CA257253 (1), R44CA285006 (1)